Cathie Wood’s ARK Invest Sells Over 300,000 Shares of Iovance Bio
One of Cathie Wood's ARK Invest funds sold over 300,000 shares of cancer-focused biopharma startup Iovance Bio on August 26.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Thursday. This fund sold over 300,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA | IOVA Price Prediction) shares, as the price of this ETF was down over 1% on Thursday. Note that this fund is still up handily in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Thursday’s closing price, this would have valued this sale at $7.0 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 36% in the past year.
Check out all of the ARK Invest sales for Thursday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 4477JP | BASE | 22,900 |
| ARKF | GOOG | ALPHABET | 131 |
| ARKF | 9923HK | YEAHKA | 252,800 |
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 638,800 |
| ARKG | BMY | BRISTOL-MYERS SQUIBB | 29,000 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 15,505 |
| ARKG | RHHBY | ROCHE | 32,600 |
| ARKG | MCRB | SERES THERAPEUTICS | 400 |
| ARKG | SEER | SEER | 20,000 |
| ARKK | NSTG | NANOSTRING TECHNOLOGIES | 144,340 |
| ARKK | NTDOY | NINTENDO | 38,500 |
| ARKK | SE | SEA | 71,593 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 302,190 |
| ARKQ | BABA | ALIBABA | 46,900 |
| ARKQ | XONE | EXONE | 10,000 |
| ARKW | LC | LENDINGCLUB | 32,700 |
| ARKW | OKTA | OKTA | 31,041 |
| ARKW | SQ | SQUARE | 21,732 |
| ARKX | TRMB | TRIMBLE | 9,167 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=942416][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
